Jeffrey M. Leiden
2012 - Vertex Pharmaceuticals
In 2012, Jeffrey M. Leiden earned a total compensation of $5.7M as Chairman, President & CEO at Vertex Pharmaceuticals, a 47% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $2,088,000 |
|---|---|
| Option Awards | $2,556,234 |
| Salary | $1,000,000 |
| Other | $12,450 |
| Total | $5,656,684 |
Leiden received $2.6M in option awards, accounting for 45% of the total pay in 2012.
Leiden also received $2.1M in non-equity incentive plan, $1M in salary and $12.5K in other compensation.
Rankings
In 2012, Jeffrey M. Leiden's compensation ranked 1,033rd out of 11,487 executives tracked by ExecPay. In other words, Leiden earned more than 91.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,033 out of 11,487 | 91st |
Division Manufacturing | 377 out of 4,253 | 91st |
Major group Chemicals And Allied Products | 88 out of 1,198 | 93rd |
Industry group Drugs | 49 out of 920 | 95th |
Industry Pharmaceutical Preparations | 44 out of 700 | 94th |
Source: SEC filing on April 30, 2015.
Leiden's colleagues
We found six more compensation records of executives who worked with Jeffrey M. Leiden at Vertex Pharmaceuticals in 2012.
2012
Matthew Emmens
Vertex Pharmaceuticals
Chief Executive Officer
2012
Stuart Arbuckle
Vertex Pharmaceuticals
EVP & Chief Commercial Officer
2012
Peter Mueller
Vertex Pharmaceuticals
Chief Scientific Officer
2012
David Howton
Vertex Pharmaceuticals
Chief Legal Officer
2012
Ian Smith
Vertex Pharmaceuticals
Chief Financial Officer
2012
Kenneth Horton
Vertex Pharmaceuticals